You are here

Article info

Article menu
Download PDFPDF
Prevention
Cohort study
A targeted approach reduces prostate cancer-specific (PSA) screening harms while preserving benefits

Authors

  1. Correspondence to : Dr Amanda Black, Division of Cancer Epidemiology & Genetics, National Cancer Institute, 9609 Medical Center Drive, Room 7E-582, Rockville, MD 20892, USA; blacka{at}mail.nih.gov
View Full Text

Citation

Black A
A targeted approach reduces prostate cancer-specific (PSA) screening harms while preserving benefits
BMJ Evidence-Based Medicine 2014;19:186.

Publication history

  • First published June 17, 2014.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions